Search Results
Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC)
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has been awarded a Gold Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC) in the categories of IV Solutions, Nutrition Solutions and Premix Drugs. Baxter is the first manufacturer to earn this distinction across these categories, underscoring Baxter’s commitment to building a stronger, more reliable supply chain.
Baxter's Response and Recovery Efforts Following Hurricane Helene
In September 2024, Hurricane Helene struck North Carolina. The hurricane's heavy rain surge triggered a levee breach, which led to water permeating our largest manufacturing plant, North Cove, and damaged the bridges that provide access to the site.
Building Resilience: Baxter’s Philanthropic Approach to Disaster Preparedness and Relief
Baxter's comprehensive support for community disaster preparedness and relief provides a lifeline to vulnerable areas during times of greatest need.
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today launched the Welch Allyn Connex 360 Vital Signs Monitor, its next generation patient monitoring device.
Where Clean Water Flows, Resilience Grows
Access to clean water is crucial for good health, sanitation and hygiene, and disease prevention. At Baxter, a healthy water supply is also critical for the well-being of our patients, the communities where we operate and our business. Unfortunately, this vital natural resource is limited in many areas of the world, disproportionately affecting communities with already constrained health infrastructures.
Recycling IV Bags: A Circular Economy Success in Colombia
For more than a decade, Baxter has successfully led programs to recycle polyvinyl chloride (PVC) IV bags in various countries around the world – an important contributor to our corporate responsibility efforts, specifically as part of how we reduce the environmental impact of our products. Not all medical products can be recycled, and therefore a dedicated and specialized recycling effort is required – and our partners must be trained to ensure appropriate products are included in the recyc
A Career Fueled by Purpose, People and Progress at Baxter
With nearly two decades of experience at Baxter, Manuel Ventosa López, Business Unit Head for Advanced Surgery Southern Europe and Country Lead for Spain, reflects on his career journey, what drives him and how his daily morning runs allow him to be the best version of himself in both his personal and professional life.
Baxter Reports Second-Quarter 2025 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025.
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156238 to pre-register for the call and receive the call information.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on October 1, 2025, to stockholders of record as of August 29, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter